Drug Combination Is OKd for Cervical Cancer
From Times Wire Reports
A new drug combination to treat women with cervical cancer won federal approval for severe cases when surgery or radiation may not work.
The drug Hycamtin helped patients live about three months longer when used with the chemotherapy agent cisplatin than they lived with cisplatin alone, the Food and Drug Administration said.
Both drugs are already on the market and approved separately to treat other cancers, including ovarian and lung.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
